CYP2E1 activation leading to neurodegeneration (Homo sapiens)
From WikiPathways
Description
CYP2E1 activation leading to neurodegeneration. This pathway is based on the Adverse Outcome Pathway by Jelle Broers on AOPWiki: https://aopwiki.org/aops/260 .
Quality Tags
Ontology Terms
Bibliography
- ''https://aopwiki.org/aops/260''; ,
History
View all... |
External references
DataNodes
| View all... |
| Name | Type | Database reference | Comment |
|---|---|---|---|
| ATF6 | GeneProduct | ENSG00000118217 (Ensembl) ![]() | |
| Acetaminophen | Metabolite | CHEBI:46195 (ChEBI) ![]() | |
| Acetylcysteine | Metabolite | CHEBI:17561 (ChEBI) ![]() | |
| Apoptosis | Pathway | WP254 (WikiPathways) ![]() | |
| BCL2 | GeneProduct | ENSG00000171791 (Ensembl) ![]() | |
| CYP2E1 activation | Pathway | WP4269 (WikiPathways) ![]() | |
| Chlorzoxazone | Metabolite | CHEBI:3655 (ChEBI) ![]() | |
| EIF2AK3 | GeneProduct | ENSG00000172071 (Ensembl) ![]() | |
| ERN1 | GeneProduct | ENSG00000178607 (Ensembl) ![]() | |
| Enflurane | Metabolite | HMDB0014373 (HMDB) ![]() | |
| Ethanol | Metabolite | CHEBI:16236 (ChEBI) ![]() | |
| Halothane | Metabolite | CHEBI:5615 (ChEBI) ![]() | |
| Isoflurane | Metabolite | CHEBI:6015 (ChEBI) ![]() | |
| Isoniazid | Metabolite | HMDB0015086 (HMDB) ![]() | |
| L(-)-Glutathione(oxidized) | Metabolite | CHEBI:17858 (ChEBI) ![]() | |
| MAPK8 | GeneProduct | ENSG00000107643 (Ensembl) ![]() | |
| Methoxyflurane | Metabolite | CHEBI:6843 (ChEBI) ![]() | |
| NFE2L2 | GeneProduct | ENSG00000116044 (Ensembl) ![]() | |
| Oxidative stress | Pathway | WP408 (WikiPathways) ![]() | |
| SOD1 | GeneProduct | ENSG00000142168 (Ensembl) ![]() | |
| Sevoflurane | Metabolite | CHEBI:9130 (ChEBI) ![]() | |
| TP53TG3C | GeneProduct | ENSG00000205457 (Ensembl) ![]() | |
| Titanium oxide | Metabolite | CHEBI:134438 (ChEBI) ![]() | |
| Unfolded protein response | Pathway | WP1939 (WikiPathways) ![]() |
Annotated Interactions
No annotated interactions
Saving...

